Eight numbers in the abstract
Where each one falls
Only readable comparisons vote
Where it lands on the map
What it changes
Among 5 other studies
the abstract, start to end
… 0.90, 95% confidence interval, CI 0.84-0.97) and the composite HF outcome (1234/57 734 vs. 1344/57 836; RR 0.92, 95% CI 0.85-0.99) but not HF …
… whether this was preceded by MI (RR 0.87, 95% CI 0.68-1.11) or not (RR 0.91, 95% CI 0.84-0.98).
… (213/57 734 vs. 220/57 836 events; RR 0.97, 95% CI 0.80-1.17) (Figure 2B).
… 238 vs. 1498/66 330 first events; RR 0.90, 95% CI 0.84-0.97) in 17 trials …
… 734 vs. 1344/57 836 first events; RR 0.92, 95% CI 0.85-0.99) (Figure 2C).
… first events in 65 530 on control; RR 0.74, 95% CI 0.70-0.78).
← favours treatmentfavours comparator →
could be chanceAdverse events & safety
RR 0.970.80–1.17
Adverse events & safety
RR 0.920.85–0.99
Adverse events & safety
RR 0.870.68–1.11
Adverse events & safety
RR 0.910.84–0.98
Cardiovascular events
RR 0.970.80–1.17
Adverse events & safety
RR 0.900.84–0.97
Adverse events & safety
RR 0.920.85–0.99
Cardiovascular events
RR 0.740.70–0.78
StatinsCardiovascular eventsAdverse events & safety
Statins × adverse events & safetyharms?mixed
unlikelylikely
0.16not counted
Statins × cardiovascular eventshelps?replicated
unlikelylikely
0.86not counted
← favours comparatorfavours treatment →
1 / 6